DE297761C - - Google Patents
Info
- Publication number
- DE297761C DE297761C DENDAT297761D DE297761DA DE297761C DE 297761 C DE297761 C DE 297761C DE NDAT297761 D DENDAT297761 D DE NDAT297761D DE 297761D A DE297761D A DE 297761DA DE 297761 C DE297761 C DE 297761C
- Authority
- DE
- Germany
- Prior art keywords
- mol
- water
- sodium
- product
- lactate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 6
- 239000001527 calcium lactate Substances 0.000 claims description 6
- 229960002401 calcium lactate Drugs 0.000 claims description 6
- 235000011086 calcium lactate Nutrition 0.000 claims description 6
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000001540 sodium lactate Substances 0.000 claims description 4
- 229940005581 sodium lactate Drugs 0.000 claims description 4
- 235000011088 sodium lactate Nutrition 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- ZZUUMCMLIPRDPI-UHFFFAOYSA-N 2-hydroxypropanoic acid;sodium Chemical group [Na].CC(O)C(O)=O ZZUUMCMLIPRDPI-UHFFFAOYSA-N 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 229960005069 calcium Drugs 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE297761C true DE297761C (enrdf_load_stackoverflow) |
Family
ID=552036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT297761D Active DE297761C (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE297761C (enrdf_load_stackoverflow) |
-
0
- DE DENDAT297761D patent/DE297761C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE297761C (enrdf_load_stackoverflow) | ||
| DE69628754T2 (de) | Leicht absorbierbares kalzium enthaltende zusammensetzung und verfahren zu ihrer herstellung | |
| DE10159244A1 (de) | Feste und stabile Kreatin/Citronensäure-Zusammensetzung(en) und Kohlenhydrat(e) bzw. deren Hydrate enthaltende Formulierung, Verfahren zu ihrer Herstellung und deren Verwendung | |
| DE2725246C2 (enrdf_load_stackoverflow) | ||
| EP1399138B1 (de) | Verfahren zur herstellung fester formulierungen von natrium-3-hydroxy-3-methylbutyrat | |
| DE2256215C3 (de) | Insulin-Zubereitung mit einem Gehalt an kristallinem Insulin und amorphem Desphenylalanin8' -insulin | |
| DE1568807C3 (de) | Verfahren zur Herstellung von aktiven Calciumsuccinaten in eis-Form | |
| AT73479B (de) | Verfahren zur Herstellung eines leicht resorbierbaren, haltbaren, nichthygroskopischen Kalkpräparates. | |
| DE558752C (de) | Verfahren zur Herstellung von neutralen komplexen Antimonsalzen | |
| DE956976C (de) | Verfahren zum Einbringen von organischen Saeuren in Gewebezellen zu kosmetischen Zwecken und bei Algen | |
| DE277437C (enrdf_load_stackoverflow) | ||
| DE854952C (de) | Verfahren zur Herstellung von komplexen Aureomycin-Verbindungen | |
| DE945926C (de) | Verfahren zur Herstellung von ªŠ-Acetyl-lysin | |
| DE633786C (de) | Verfahren zur Herstellung von Komplexverbindungen des 1, 3-Dimethylxanthins | |
| DE629841C (de) | Verfahren zur Herstellung einer waessrigen Chininloesung fuer Injektionszwecke | |
| DE525651C (de) | Verfahren zur Herstellung von in Wasser Ioeslichen und bestaendigen Komplexverbindungen des 5wertigen Antimons | |
| DE817463C (de) | Gelierende Mittel | |
| DE101860C (enrdf_load_stackoverflow) | ||
| DE202169C (enrdf_load_stackoverflow) | ||
| DE359583C (de) | Mittel zur Schaedlingsbekaempfung | |
| DE343150C (de) | Verfahren zur Darstellung von Salzen der Verbindungen von Gerbsaeuren oder Gallussaeure und Milchsaeure | |
| AT79103B (de) | Verfahren zur Herstellung neuer Isovaleriansäurepräparate. | |
| DE624061C (de) | Verfahren zur Herstellung wasserloeslicher Silbersalze der Acetylsalicylsaeure | |
| DE852119C (de) | Verfahren zur Herstellung haltbarer Desinfektionsmittel, insbesondere fuer therapeutische Zwecke | |
| DE604070C (de) | Verfahren zur Herstellung von neutralloeslichen Komplexsalzen des dreiwertigen Antimons |